UTv Videos

“This test requires just one millimeter of cancer on a biopsy on five consecutive slides,” says Eric A. Klein, MD.

“We found that a remarkable percentage of patients were getting narcotics refills from non urologists,” said Jay Simhan, MD, FACS.

“As we suspected, the more work interfered with their freedom to use the restroom, the fewer times they urinated during the work day,” says W. Stuart Reynolds, MD, MPH, FACS.

“For now, the UMPIRE [study] protocol will continue to withhold prophylaxis in the newborn population,” says investigator M. Chad Wallis, MD, FACS.

“The way I think about this test now is… more as a dichotomous score,” says Eric A. Klein, MD.

“It’s really fascinating how the field is expanding,” Klein says.

“The take-home message is that for the appropriate patient, each of [these] technologies works well,” says Richard K. Lee, MD, MBA.

“It’s an extremely useful tool,” says Jonathan D. Tward, MD, PhD, of the Prolaris test.

Investigators observed a decline in the number of men obtaining repeat postvasectomy semen analyses.

“I find [the Prolaris test] to be a very helpful clinical tool,” says Jonathan D. Tward, MD, PhD.

“We continue to see a building story of benefit of statin medications in men who have prostate cancer,” says Robert J. Hamilton, MD, MPH.

Chris Du, MD, discusses findings from a study published in Neurourology and Urodynamics.

Investigators evaluated uropathogen prevalence and antibiotic resistance in a urogynecologic patient population.

Attorney Kenton H. Steele, Esq, discusses his recent Urology Times® column.

Rena Malik, MD, discusses findings from a recent Urology Practice study.

Researchers evaluated the use of interprofessional consultations within the specialty of urology.

Only 5% of websites studied discuss risks of treatments, investigators found.

Reza Z. Goharderakhshan, MD, discusses how patient compliance for recommended studies increased from less than 10% to 82% following implementation of the program.

“Listen. Be emphatic. Be transparent,” Pansy Uberoi, MD, MPH, advises in this interview.

Victoria S. Edmonds and Tobias Köhler, MD, MPH, discuss trends in reimbursement for men's health procedures from 2002 to 2020.

Murphy shares the backstory of how PSMA PET/CT imaging has emerged as a major advancement in the prostate cancer armamentarium.

Gomella looks back on the year's top headlines in bladder cancer, from FDA approvals to notable clinical trial results.

“Some women described not being told any risks of the surgery… while other women did recall having risks described,” says investigator Pansy Uberoi, MD, MPH.

Urology residency program applicants continue to face interview questions on restricted topics such as plans for having children.

Investigators observed a median 74% reduction in urinary incontinence episodes at 1 year for women undergoing group-based pelvic floor muscle training compared with a 70% reduction in women undergoing individual PFMT.

Christopher P. Evans, MD, discusses his active surveillance protocol with J. Brantley Thrasher, MD.

Samuel J. Peretsman, MD, explains how he incorporated HIFU into his practice.

Anne M. Suskind, MD, MS, discusses the findings of the recent study, published in Urology.